JP Morgan Maintains Overweight on US Physical Therapy, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 50.1%

Neg 0% Neu 0% Pos 50.1%

JP Morgan analyst Benjamin Rossi maintains US Physical Therapy (NYSE:USPH) with a Overweight and raises the price target from $90 to $95.